Article

Thyroid disorder may heighten risk of glaucoma

Patients with glaucoma were 38% more likely to have had a thyroid disorder at some point in their lives than those without, according to a study published in the British Journal of Ophthalmology.

Birmingham, AL-Patients with glaucoma were 38% more likely to have had a thyroid disorder at some point in their lives than those without, according to a study published in the British Journal of Ophthalmology. Statistics were gathered from 12,376 people who participated in the 2002 National Health Interview Survey.

Participants were asked whether they ever had been diagnosed with a thyroid gland disorder or glaucoma. Slightly more than 4.5% of participants said glaucoma was diagnosed and 12% said a thyroid problem was diagnosed. The percentage of patients with glaucoma who said they had suffered a thyroid problem was 6.5% to 4.4% who had not.

An underactive thyroid can promote chemical deposits in the blood vessels serving the eye, which can spark an increase in IOP, said study authors.

Patients with thyroid problems should see an ophthalmologist or make their ophthalmologist aware of their thyroid condition, said lead researcher Gerald McGwin, PhD, vice chairman of the Department of Ophthalmology, University of Alabama School of Medicine, Birmingham.

"Somebody who has a history of thyroid problems and has not seen an ophthalmologist may have a heightened level of concern about their eyesight," he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.